Daurismo ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

daurismo

pfizer europe ma eeig - glasdegib maleate - leukémia, myeloidná, akútna - antineoplastické činidlá - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.